# Combination Therapy of Severe Aplastic Anemia

> **NCT00001964** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 104 (actual)

## Conditions studied

- Severe Aplastic Anemia

## Interventions

- **DRUG:** Cyclosporine A
- **DRUG:** ATG
- **DRUG:** MMF

## Key facts

- **NCT ID:** NCT00001964
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03-17
- **Primary completion:** 2003-12-09
- **Final completion:** 2015-05-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001964, "Combination Therapy of Severe Aplastic Anemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00001964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*